Surgical management shows similar IOP levels in glaucoma patients post-kP, suggesting trabeculectomy may enhance visual acuity.
Purpose: To evaluate the visual results, intraocular pressure (IOP), use of antiglaucomatous medications, corneal graft survival rates, and complications after trabeculectomy and Ahmed glaucoma valve (AGV) implantation in patients with a history of keratoplasty (KP). Methods: A comprehensive analysis was conducted on all patient records from the Akdeniz University Medical Faculty Ophthalmology Department who had glaucoma surgery after KP between 2014 and 2022. This corresponds to a total of 49 eyes of 49 patients. Results: The mean visual acuity after AGV implantation was 1.9 ± 1.13 logMAR; in the trabeculectomy group, it was 1.2 ± 0.82 logMAR ( P = 0.028). The mean IOP levels 6 months after AGV implantation was 15.9 ± 5.02 mmHg , and in the trabeculectomy group, it was 13.8 ± 3.43 mmHg ( P = 0.170). The mean IOP levels at the patients’ last visits in the AGV implantation group was 14.3 ± 3.93 mmHg, and in the trabeculectomy group, it was 13.7 ± 3.32 mmHg ( P = 0.983). While the average number of antiglaucomatous drugs used by the patients before the glaucoma surgery in the AGV group was 3.5 ± 0.69, it was 3.6 ± 0.82 in the trabeculectomy group. In the AGV group, patients used an average of 1 ± 1.03 antiglaucomatous drugs after surgery, whereas in the trabeculectomy group, it was 0.7 ± 0.97. Graft failure was statistically significantly more common in the AGV group (9 patients [45%] in the AGV group and 5 patients [17.2%] in the trabeculectomy group) ( P = 0.0497). Conclusions: Both AGV and trabeculectomy resulted in comparable postoperative IOP levels. However, the trabeculectomy group demonstrated better visual acuity and higher corneal graft survival rates. Given these findings, trabeculectomy could be a favorable choice for glaucoma patients following KP, even considering the potential risk of postoperative hypotony. Ultimately, the treatment decision should be individualized based on each patient’s specific circumstances and needs.
No takes yet. Share an insight, caveat, or question.
Ayaz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: